These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 34835405)
1. In Vitro Killing of Canine Urinary Tract Infection Pathogens by Ampicillin, Cephalexin, Marbofloxacin, Pradofloxacin, and Trimethoprim/Sulfamethoxazole. Blondeau JM; Fitch SD Microorganisms; 2021 Nov; 9(11):. PubMed ID: 34835405 [TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro killing of canine strains of Staphylococcus pseudintermedius and Escherichia coli by cefovecin, cefazolin, doxycycline and pradofloxacin. Blondeau JM; Shebelski SD Vet Dermatol; 2016 Aug; 27(4):267-e63. PubMed ID: 27307405 [TBL] [Abstract][Full Text] [Related]
3. In vitro killing of canine strains of Staphylococcus pseudintermedius and Escherichia coli by cefazolin, cefovecin, doxycycline and pradofloxacin over a range of bacterial densities. Blondeau JM; Fitch SD Vet Dermatol; 2020 Jun; 31(3):187-e39. PubMed ID: 31825131 [TBL] [Abstract][Full Text] [Related]
4. Comparative In Vitro Killing by Pradofloxacin in Comparison to Ceftiofur, Enrofloxacin, Florfenicol, Marbofloxacin, Tildipirosin, Tilmicosin and Tulathromycin against Bovine Respiratory Bacterial Pathogens. Blondeau JM; Fitch SD Microorganisms; 2024 May; 12(5):. PubMed ID: 38792823 [TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibilities of canine urinary bacteria to selected antimicrobial agents. Rohrich PJ; Ling GV; Ruby AL; Jang SS; Johnson DL J Am Vet Med Assoc; 1983 Oct; 183(8):863-7. PubMed ID: 6415021 [TBL] [Abstract][Full Text] [Related]
6. Antimicrobial Susceptibility Monitoring of Bacterial Pathogens Isolated from Urinary Tract Infections in Dogs and Cats Across Europe: ComPath Results. Moyaert H; Morrissey I; de Jong A; El Garch F; Klein U; Ludwig C; Thiry J; Youala M Microb Drug Resist; 2017 Apr; 23(3):391-403. PubMed ID: 28384093 [TBL] [Abstract][Full Text] [Related]
7. [Antibiotic sensitivity of bacteria isolated from the urine of children with urinary tract infections from 1986 to 1995]. Lazarević G; Petreska D; Pavlović S Srp Arh Celok Lek; 1998; 126(11-12):423-9. PubMed ID: 9921014 [TBL] [Abstract][Full Text] [Related]
8. Time-Kill Analysis of Canine Skin Pathogens: A Comparison of Pradofloxacin and Marbofloxacin. Azzariti S; Mead A; Toutain PL; Bond R; Pelligand L Antibiotics (Basel); 2023 Oct; 12(10):. PubMed ID: 37887249 [TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Trimethoprim and Sulfamethoxazole-Resistant Escherichia Coli in ED Patients with Urinary Tract Infections. Wesolek JL; Wu JY; Smalley CM; Wang L; Campbell MJ Am J Emerg Med; 2022 Jun; 56():178-182. PubMed ID: 35405469 [TBL] [Abstract][Full Text] [Related]
10. Ofloxacin versus trimethoprim/sulfamethoxazole in the treatment of uncomplicated urinary tract infection. Cox CE; Serfer HS; Mena HR; Briefer C; Childs SJ; Gordon SF; Zoller JS Clin Ther; 1992; 14(3):446-57. PubMed ID: 1638586 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens. Hansen GT; Blondeau JM J Chemother; 2005 Oct; 17(5):484-92. PubMed ID: 16323436 [TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors for trimethoprim-sulfamethoxazole-resistant Escherichia coli among women with acute uncomplicated urinary tract infection in a developing country. Gangcuangco LM; Alejandria M; Henson KE; Alfaraz L; Ata RM; Lopez M; Saniel M Int J Infect Dis; 2015 May; 34():55-60. PubMed ID: 25748571 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999. Karlowsky JA; Jones ME; Thornsberry C; Critchley I; Kelly LJ; Sahm DF Int J Antimicrob Agents; 2001 Aug; 18(2):121-7. PubMed ID: 11516934 [TBL] [Abstract][Full Text] [Related]
14. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria. Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769 [TBL] [Abstract][Full Text] [Related]
15. Bactericidal properties of pradofloxacin against veterinary pathogens. Silley P; Stephan B; Greife HA; Pridmore A Vet Microbiol; 2012 May; 157(1-2):106-11. PubMed ID: 22209121 [TBL] [Abstract][Full Text] [Related]
16. Susceptibility of canine and feline bacterial pathogens to pradofloxacin and comparison with other fluoroquinolones approved for companion animals. Schink AK; Kadlec K; Hauschild T; Brenner Michael G; Dörner JC; Ludwig C; Werckenthin C; Hehnen HR; Stephan B; Schwarz S Vet Microbiol; 2013 Feb; 162(1):119-26. PubMed ID: 22939523 [TBL] [Abstract][Full Text] [Related]
17. Canine urinary tract infections: a comparison of in vitro antimicrobial susceptibility test results and response to oral therapy with ampicillin or with trimethoprim-sulfa. Ling GV; Rohrich PJ; Ruby AL; Johnson DL; Jang SS J Am Vet Med Assoc; 1984 Aug; 185(3):277-81. PubMed ID: 6332102 [TBL] [Abstract][Full Text] [Related]
18. The Role of Urinary Nitrite in Predicting Bacterial Resistance in Urine Culture Analysis Among Patients With Uncomplicated Urinary Tract Infection. Papava V; Didbaridze T; Zaalishvili Z; Gogokhia N; Maziashvili G Cureus; 2022 Jun; 14(6):e26032. PubMed ID: 35865430 [TBL] [Abstract][Full Text] [Related]
19. First-Line Antimicrobial Resistance Patterns of Escherichia coli in Children With Urinary Tract Infection in Emergency Department and Primary Care Clinics. Ahmed MN; Vannoy D; Frederick A; Chang S; Lawler E Clin Pediatr (Phila); 2016 Jan; 55(1):19-28. PubMed ID: 26040907 [TBL] [Abstract][Full Text] [Related]
20. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Raz R; Chazan B; Kennes Y; Colodner R; Rottensterich E; Dan M; Lavi I; Stamm W; Clin Infect Dis; 2002 May; 34(9):1165-9. PubMed ID: 11941541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]